Early cytopenias and infections following chimeric antigen receptor T-Cell therapy for hematologic malignancies

Leuk Lymphoma. 2023 Sep;64(9):1592-1595. doi: 10.1080/10428194.2023.2220455. Epub 2023 Jun 7.

Authors

Mary McGann¹, Arash Velayati², Kiera Roubal¹, Katelynn Granger¹, James A Davis¹, Kelly J Gaffney¹, Erin Weeda³, Hamza Hashmi²

Affiliations

¹ Department of Pharmacy, Medical University of South Carolina, Charleston, SC, USA.
² Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC, USA.
³ Medical University of South Carolina College of Pharmacy, Charleston, SC, USA.

PMID: 37287328
DOI: 10.1080/10428194.2023.2220455

No abstract available

Publication types

Letter
Comment

MeSH terms

Cell- and Tissue-Based Therapy
Hematologic Neoplasms* / therapy
Humans
Immunotherapy, Adoptive / adverse effects
Receptors, Antigen, T-Cell / genetics
Receptors, Chimeric Antigen* / genetics

Substances

Receptors, Chimeric Antigen
Receptors, Antigen, T-Cell